硼替卡2毫克注射液

What is Bortezomib Injection?
Bortezomib Injection is a targeted therapy medication used to treat certain types of cancer, primarily multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs called proteasome inhibitors.

Active Ingredient and How it Works:
The active ingredient is Bortezomib. Bortezomib works by inhibiting proteasomes, which are protein complexes within cells responsible for breaking down unneeded or damaged proteins. By blocking proteasomes, Bortezomib causes an accumulation of these proteins within cancer cells, leading to cell damage and death. This targeted action helps to slow down or stop the growth of cancer cells.

Indications:
Bortezomib Injection is indicated for the treatment of:

• Multiple Myeloma: Typically used in patients who have received at least one prior therapy, or as a first-line treatment in combination with other chemotherapy drugs.
• Mantle Cell Lymphoma: Used in patients whose disease has relapsed or progressed after at least one prior therapy.

Dosage:
The dosage and administration of Bortezomib Injection are determined by a healthcare professional based on the patient’s specific condition, response to treatment, and other factors. It is usually administered subcutaneously (under the skin) or intravenously (into a vein). It is crucial to follow the prescribed dosage and schedule precisely.

Side Effects:
Common side effects may include fatigue, nausea, diarrhea, constipation, loss of appetite, decreased platelet count, and peripheral neuropathy (nerve damage causing numbness, tingling, or pain in the hands and feet). Serious side effects can also occur, and patients should report any unusual symptoms to their doctor immediately.

Storage:
Unused Bortezomib Injection vials should be stored at room temperature, protected from light. Once reconstituted, the solution should be used promptly. Always follow the specific storage instructions provided by the manufacturer and your healthcare provider.